Ajanta Pharma Limited

532331

Equity

ISIN INE031B01049 / Valor 27480449

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-01)

INR 3,505.05-3.18%

Ajanta Pharma Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Ajanta Pharma Limited is an India-based pharmaceutical company that develops, manufactures and markets finished-dosage formulations, primarily as branded generics, for domestic and international customers. Its product portfolio covers therapeutic areas such as ophthalmology, dermatology, cardiology and anti-infectives and includes oral solids, injectables, ophthalmic solutions and topical preparations. The company sells through a mix of direct sales forces and distributor networks, with significant presence in India and across emerging markets in Asia, Africa, Latin America and the CIS, and it also pursues regulatory approvals and exports to more regulated markets. Ajanta’s business model combines in-house formulation R&D and manufacturing with market-specific commercialization to drive revenue from both domestic branded sales and overseas distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

42.9%1Y

104%3Y

135%5Y

Performance

26.2%1Y

31.4%3Y

29.2%5Y

Volatility